Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
OTC Markets Group Expands Data Availability via ICE Consolidated Feed, Unlocking Greater Global Access to Overnight Trading
From OTC Markets
Via GlobeNewswire
Tickers ICE OTCM
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Sable Offshore Corp. (NYSE: SOC)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers SOC
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Flywire Corporation (NASDAQ: FLYW)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers FLYW
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S (NYSE: NVO)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers NVO
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against KinderCare Learning Companies, Inc. (NYSE: KLC)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers KLC
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Dow Inc. (NYSE: DOW)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers DOW
Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases
From Monte Rosa Therapeutics, Inc.
Via GlobeNewswire
Tickers GLUE
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against C3.ai, Inc. (NYSE: AI)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers AI
Can-Fite Reports Complete Resolution of Esophageal Varices in Decompensated Cirrhosis Patient Treated with Namodenoson
From Can-Fite BioPharma Ltd.
Via GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Fly-E Group, Inc. (NASDAQ: FLYE)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers FLYE
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Charter Communications, Inc. (NASDAQ: CHTR)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers CHTR
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against SelectQuote, Inc. (NYSE: SLQT)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers SLQT
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lockheed Martin Corporation (NYSE: LMT)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers LMT
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. (NASDAQ: REPL)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers REPL
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Snap Inc. (NYSE: SNAP)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers SNAP
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lineage, Inc. (NASDAQ: LINE)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers LINE
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Tronox Holdings PLC (NYSE: TROX)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers TROX
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against RxSight, Inc. (NASDAQ: RXST)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers RXST
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against LifeMD, Inc. (NASDAQ: LFMD)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers LFMD
Perspective Therapeutics Progresses Dose Finding for [212Pb]VMT01 in Combination with Nivolumab in its Ongoing Phase 1/2a Study of MC1R-Positive Metastatic Melanoma
From Perspective Therapeutics, Inc.
Via GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Nutex Health Inc. (NASDAQ: NUTX)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers NUTX
Adamas Trust Declares Third Quarter 2025 Common Stock Dividend of $0.23 Per Share, and Preferred Stock Dividends
From Adamas Trust, Inc.
Via GlobeNewswire
Tickers NYMT
Bunker Hill Updates Previously Announced C$45 Million “Bought Deal” Private Placement of Units to Provide for Canadian Dollar And U.S. Dollar Denominated Tranches
From Bunker Hill Mining Corp.
Via GlobeNewswire
Tickers BHLL TSX-V:BNKR
Descartes’ 9th Annual Study Finds Transportation Management Reaches Record Strategic Importance
From The Descartes Systems Group Inc
Via GlobeNewswire
Tickers DSGX TSX:DSG
DallasNews Corporation Announces Amendment to Hearst Merger Agreement with a Final Increase to the Purchase Price
From DallasNews Corporation
Via GlobeNewswire
Tickers DALN
FTAI Aviation Ltd. Announces Timing of Third Quarter 2025 Earnings and Conference Call
From FTAI Aviation Ltd.
Via GlobeNewswire
Tickers FTAI
August Retail Sales Revenue Grew 2% Despite Lacking Consumer Demand, Reports Circana
From Circana
Via GlobeNewswire
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
From Ocugen
Via GlobeNewswire
Tickers OCGN
Soleo Health Promotes Holly Flax to Chief Operating Officer
From Soleo Health Holdings, Inc.
Via GlobeNewswire
Tyton Partners Releases Listening to Learners 2025: Awareness of Services, Belonging, and Career Readiness Drive Success (ABCs of Persistence)
From Tyton Partners
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.